Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dadiomov

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Pharmacoepidemiology and Drug Safety|August 26, 2021
Prevalence and distribution of high-risk prescription opioid use in the United States, 2011-2016Carter D McCormick, David Dadiomov, Rebecca Trotzky-Sirr, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Nitric Oxide Donor Sodium Nitroprusside Reduces Racemic Ketamine-But Not Esketamine-Induced Pain ReliefAlbert Dahan, Simone Jansen, Rutger van der Schrier, et al.
The Mental Health Clinician|February 5, 2024
Adverse childhood experiences among California student pharmacistsShawn R Smith, Leslie Banuelos, Nalea Trujillo, et al.
The Mental Health Clinician|June 4, 2026
Board-certified psychiatric pharmacists in substance use disorder treatment: Integration, services, and outcomes across care settingsAnuja Vallabh, Audrey Abelleira, Amber R Douglass, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 7, 2021
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemicAlyssa M Peckham, Jennifer Ball, Michelle D Colvard, et al.
Journal of Addiction Medicine|July 15, 2022
Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year LaterAmy J Kennedy, James S George, Gina Rossetti, et al.
Archives of Public Health = Archives Belges De Sante Publique|April 25, 2024
Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacyTyler J Varisco, Hannah Fish, Joshua Bolin, et al.
Drug and Alcohol Dependence Reports|July 29, 2025
Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panelTyler J Varisco, Douglas Thornton, Taha Hussain, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pharmacoepidemiology and Drug Safety|August 26, 2021
Prevalence and distribution of high-risk prescription opioid use in the United States, 2011-2016Carter D McCormick, David Dadiomov, Rebecca Trotzky-Sirr, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Nitric Oxide Donor Sodium Nitroprusside Reduces Racemic Ketamine-But Not Esketamine-Induced Pain ReliefAlbert Dahan, Simone Jansen, Rutger van der Schrier, et al.
The Mental Health Clinician|February 5, 2024
Adverse childhood experiences among California student pharmacistsShawn R Smith, Leslie Banuelos, Nalea Trujillo, et al.
The Mental Health Clinician|June 4, 2026
Board-certified psychiatric pharmacists in substance use disorder treatment: Integration, services, and outcomes across care settingsAnuja Vallabh, Audrey Abelleira, Amber R Douglass, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 7, 2021
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemicAlyssa M Peckham, Jennifer Ball, Michelle D Colvard, et al.
Journal of Addiction Medicine|July 15, 2022
Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year LaterAmy J Kennedy, James S George, Gina Rossetti, et al.
Archives of Public Health = Archives Belges De Sante Publique|April 25, 2024
Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacyTyler J Varisco, Hannah Fish, Joshua Bolin, et al.
Drug and Alcohol Dependence Reports|July 29, 2025
Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panelTyler J Varisco, Douglas Thornton, Taha Hussain, et al.
Pageof 2